Related Experiment Videos
Preischemic flap washout and its effect on the no-reflow phenomenon
Plastic and Reconstructive Surgery
|November 1, 1985
Summary
Preischemic perfusion washout with acellular solution delays no-reflow and improves tissue survival in rat flaps. This suggests stagnant blood, not perfusate, causes ischemia-induced damage.
Area of Science:
- Biomedical Engineering
- Surgical Research
- Vascular Biology
Background:
- The no-reflow phenomenon, characterized by impaired blood flow post-ischemia, compromises tissue survival.
- Stagnant blood and its components, such as hemolyzed products, are implicated in capillary endothelial damage.
- Understanding mechanisms of ischemia-reperfusion injury is crucial for improving surgical outcomes.
Purpose of the Study:
- To investigate the effect of preischemic perfusion washout on the no-reflow phenomenon and tissue survival.
- To evaluate the role of stagnant blood versus perfusate components in ischemia-induced vascular damage.
Main Methods:
- Rat epigastric free flaps underwent 18 and 24 hours of normothermic ischemia.
- Preischemic perfusion washout with an acellular physiologic solution was performed.
- No-reflow phenomenon and tissue survival were assessed.
Main Results:
- Perfusion washout significantly delayed the onset of the no-reflow phenomenon.
- Improved tissue survival was observed in flaps treated with perfusion washout.
- The findings suggest stagnant blood, not the perfusate, is a primary contributor to endothelial damage.
Conclusions:
- Preischemic perfusion washout is a viable strategy to mitigate ischemia-reperfusion injury in free flaps.
- Preventing stagnant blood accumulation may prevent capillary endothelial damage and improve flap viability.
- Further research is needed to elucidate the specific role of perfusate components.